These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38598200)

  • 1. Treating Bipolar Depression Using Psilocybin-Validity Threats Regarding Efficacy and Safety.
    Fried EI; Cristea IA; Naudet F
    JAMA Psychiatry; 2024 Jun; 81(6):633-634. PubMed ID: 38598200
    [No Abstract]   [Full Text] [Related]  

  • 2. Treating Bipolar Depression Using Psilocybin-Validity Threats Regarding Efficacy and Safety-Reply.
    Aaronson ST; van der Vaart A; Sackeim HA
    JAMA Psychiatry; 2024 Jun; 81(6):634. PubMed ID: 38598225
    [No Abstract]   [Full Text] [Related]  

  • 3. Psilocybin in Bipolar II Study Provides Preliminary Data on Safety.
    Yaden DB; Gukasyan N; Nayak SM
    JAMA Psychiatry; 2024 Jun; 81(6):541-542. PubMed ID: 38055240
    [No Abstract]   [Full Text] [Related]  

  • 4. Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes: A Nonrandomized Open-Label Trial.
    Aaronson ST; van der Vaart A; Miller T; LaPratt J; Swartz K; Shoultz A; Lauterbach M; Sackeim HA; Suppes T
    JAMA Psychiatry; 2024 Jun; 81(6):555-562. PubMed ID: 38055270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psilocybin--summary of knowledge and new perspectives.
    Tylš F; Páleníček T; Horáček J
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):342-56. PubMed ID: 24444771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study.
    Bogenschutz MP; Forcehimes AA; Pommy JA; Wilcox CE; Barbosa PC; Strassman RJ
    J Psychopharmacol; 2015 Mar; 29(3):289-99. PubMed ID: 25586396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer.
    Grob CS; Danforth AL; Chopra GS; Hagerty M; McKay CR; Halberstadt AL; Greer GR
    Arch Gen Psychiatry; 2011 Jan; 68(1):71-8. PubMed ID: 20819978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders.
    Thomas K; Malcolm B; Lastra D
    J Psychoactive Drugs; 2017; 49(5):446-455. PubMed ID: 28481178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hallucinogens as medicine.
    Griffths RR; Grob CS
    Sci Am; 2010 Dec; 303(6):76-9. PubMed ID: 21141361
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews.
    Dos Santos RG; Bouso JC; Alcázar-Córcoles MÁ; Hallak JEC
    Expert Rev Clin Pharmacol; 2018 Sep; 11(9):889-902. PubMed ID: 30102078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psilocybin in Treatment-Resistant Depression.
    Madras BK
    N Engl J Med; 2022 Nov; 387(18):1708-1709. PubMed ID: 36322849
    [No Abstract]   [Full Text] [Related]  

  • 12. The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act.
    Johnson MW; Griffiths RR; Hendricks PS; Henningfield JE
    Neuropharmacology; 2018 Nov; 142():143-166. PubMed ID: 29753748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trial of Psilocybin versus Escitalopram for Depression.
    Carhart-Harris R; Giribaldi B; Watts R; Baker-Jones M; Murphy-Beiner A; Murphy R; Martell J; Blemings A; Erritzoe D; Nutt DJ
    N Engl J Med; 2021 Apr; 384(15):1402-1411. PubMed ID: 33852780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Not imagining it. Research into hallucinogens cautiously resumes.
    Biello D
    Sci Am; 2006 Nov; 295(5):33-5. PubMed ID: 17076078
    [No Abstract]   [Full Text] [Related]  

  • 15. Psilocybin: A brief overview for psychiatric mental health nurse practitioners.
    Fradkin D
    Perspect Psychiatr Care; 2022 Jul; 58(3):1200-1203. PubMed ID: 34101846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Psilocybin's Adverse Effects Mostly Resolved Within 2 Days.
    Harris E
    JAMA; 2024 May; 331(20):1699. PubMed ID: 38700847
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.
    Gukasyan N; Davis AK; Barrett FS; Cosimano MP; Sepeda ND; Johnson MW; Griffiths RR
    J Psychopharmacol; 2022 Feb; 36(2):151-158. PubMed ID: 35166158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history.
    Pearson C; Siegel J; Gold JA
    J Neurol Sci; 2022 Mar; 434():120096. PubMed ID: 34942586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are Magic Mushrooms Really Magic?: Psilocybin in the Treatment of Depression.
    Balon R
    J Clin Psychopharmacol; 2022 Nov-Dec 01; 42(6):515-516. PubMed ID: 36251379
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.
    Davis AK; Barrett FS; May DG; Cosimano MP; Sepeda ND; Johnson MW; Finan PH; Griffiths RR
    JAMA Psychiatry; 2021 May; 78(5):481-489. PubMed ID: 33146667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.